Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis Case report

被引:11
作者
Guppy, Kern H. [1 ]
Akins, Paul T. [1 ]
Moes, Gregory S. [1 ]
Prados, Michael D. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurosurg, Kaiser Permanente Med Grp, Sacramento, CA 95825 USA
关键词
spinal cord oligodendroglioma; oligodendrogliomatosis; spinal cord tumor; 1p deletion; 19q deletion; cytogenetics; temozolomide; RAISED INTRACRANIAL-PRESSURE; ANAPLASTIC OLIGODENDROGLIOMA; LEPTOMENINGEAL OLIGODENDROGLIOMA; INTRAMEDULLARY OLIGODENDROGLIOMA; SURGICAL-MANAGEMENT; GLIOMATOSIS; TUMORS; DISSEMINATION; MENINGEAL; CHILDREN;
D O I
10.3171/2009.2.SPINE08853
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Oligodendroglioma of the spinal cord is a rare tumor that most often presents with spinal cord symptoms. The authors present a case of spinal cord oligodendroglioma that was associated with cerebral rather than spinal cord symptoms. A 30-year-old woman developed nausea, vomiting, and severe headaches. Magnetic resonance imaging of the brain showed meningeal enhancement. The patient underwent a craniotomy with biopsies of the meninges and brain. The biopsy findings revealed an abnormal arachnoid thickening without tumor cells. The patient later developed hydrocephalus and underwent shunt placement. Cerebrospinal fluid cytological findings were negative for tumor cells or infection. She was found to have a cervical cord lesion at C3-4 that was initially nonenhancing but later enhanced after Gd administration. Biopsy of the cord lesion with partial resection showed a WHO Grade 11 oligodendroglioma with 1p and 19q deletions determined by fluorescence in situ hybridization. Neurooncological treatment with tumor radiation and temozolomide (Temodor) resulted in improvement in radiographic findings, symptoms, and long-term survival. This paper presents an extensive review of the literature, which revealed only 2 other reported cases of cerebral symptoms in adults that preceded spinal cord symptoms in a patient with oligodendroglioma of the spinal cord. It is also the first reported case of oligodendroglimatosis due to a cervical spinal cord oligodendroglioma with I p and 19q deletions. (DOI: 10.3171/2009.2.SPINE08853)
引用
收藏
页码:557 / 563
页数:7
相关论文
共 50 条
  • [31] How I treat anaplastic glioma without 1p/19q codeletion
    Berghoff, Anna
    van den Bent, Martin
    [J]. ESMO OPEN, 2019, 4
  • [32] Dural Metastasis of Atypical Extraventricular Neurocytoma with the Codeletion of Chromosomes 1p/19q
    Wang, L.
    Chen, G.
    Wei, H.
    Liu, F.
    Hu, H.
    Zhang, J.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (05) : 2020 - 2026
  • [33] MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion status
    Sherman, Jonathan H.
    Prevedello, Daniel M.
    Shah, Lubdha
    Raghavan, Prashant
    Pouratian, Nader
    Starke, Robert M.
    Lopes, M. Beatriz S.
    Shaffrey, Mark E.
    Schiff, David
    [J]. ACTA NEUROCHIRURGICA, 2010, 152 (11) : 1827 - 1834
  • [34] 1p/19q codeletion and RET rearrangements in small-cell lung cancer
    Lu, Hongyang
    Xu, Haimiao
    Xie, Fajun
    Qin, Jing
    Han, Na
    Fan, Yun
    Mao, Weimin
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 3571 - 3577
  • [35] Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas
    Lin, Andrew L.
    Liu, Jingxia
    Evans, John
    Leuthardt, Eric C.
    Rich, Keith M.
    Dacey, Ralph G.
    Dowling, Joshua L.
    Kim, Albert H.
    Zipfel, Gregory J.
    Grubb, Robert L.
    Huang, Jiayi
    Robinson, Clifford G.
    Simpson, Joseph R.
    Linette, Gerald P.
    Chicoine, Michael R.
    Tran, David D.
    [J]. NEURO-ONCOLOGY, 2014, 16 (01) : 123 - 130
  • [36] Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy
    Branzoli, Francesca
    Pontoizeau, Clement
    Tchara, Lucien
    Di Stefano, Anna Luisa
    Kamoun, Aurelie
    Deelchand, Dinesh K.
    Valabregue, Romain
    Lehericy, Stephane
    Sanson, Marc
    Ottolenghi, Chris
    Marjanska, Malgorzata
    [J]. NEURO-ONCOLOGY, 2019, 21 (06) : 765 - 774
  • [37] Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade
    Iwadate, Yasuo
    Matsutani, Tomoo
    Hara, Ayaka
    Hirono, Seiichiro
    Ikegami, Shiro
    Kobayashi, Masayoshi
    Ito, Daisuke
    Kawauchi, Daisuke
    Horiguchi, Kentaro
    Tamiya, Ado
    Higuchi, Yoshinori
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2019, 141 (01) : 205 - 211
  • [38] Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas
    Yang, B.
    Hao, X. Q.
    Zeng, X. W.
    Ji, T. L.
    Pan, S.
    Feng, Y. G.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2016, 15 (01):
  • [39] Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss
    Snuderl, Matija
    Eichler, April F.
    Ligon, Keith L.
    Vu, Quynh U.
    Silver, Michael
    Betensky, Rebecca A.
    Ligon, Azra H.
    Wen, Patrick Y.
    Louis, David N.
    Iafrate, A. John
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (20) : 6430 - 6437
  • [40] Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience
    J. S. Frenel
    C. Leux
    D. Loussouarn
    A.-G. Le Loupp
    F. Leclair
    M. Aumont
    A. Mervoyer
    S. Martin
    M. G. Denis
    M. Campone
    [J]. Journal of Neuro-Oncology, 2013, 114 : 85 - 91